Thelansis

Wasting Syndrome (Cachexia) Market Outlook Thelansis’s “Wasting Syndrome (Cachexia) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Wasting Syndrome (Cachexia) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the mar...

  Wasting Syndrome (Cachexia) Market Outlook Thelansis’s “Wasting Syndrome (Cachexia) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Wasting Syndrome (Cachexia) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Wasting Syndrome (Cachexia) Overview Cachexia is a complex metabolic syndrome that arises from an underlying illness and is characterized by the loss of muscle mass, with or without the loss of fat mass. It often presents with anorexia, an inflammatory process, insulin resistance, and increased protein turnover. Cachexia leads to weight loss and an elevated risk of mortality. The primary cause of cachexia is an excess of ...

 Cachexia is a complex metabolic syndrome that arises from an underlying illness and is characterized by the loss of muscle mass, with or without the loss of fat mass. It often presents with anorexia, an inflammatory process, insulin resistance, and increased protein turnover. Cachexia leads to weight loss and an elevated risk of mortality. The primary cause of cachexia is an excess of cytokines. Additional contributing factors include deficiencies in testosterone and insulin-like growth factor-I, overabundance of myostatin, and excess glucocorticoids. Cachexia is distinguished by a persistent increase in the body's basal metabolic rate that is not compensated by an adequate intake of calories and protein. Various factors contribute to this abnormal metabolic cascade, including digestive issues, tumor-related factors, and hormonal responses to the underlying disease. Digestive factors that contribute to poor intake include dysgeusia (distorted sense of taste), nausea, dysphagia (di...